The effect of recombinant granulocyte colony-stimulating factor (rG-CSF) on acute disseminated Candida albicans infection in nonneutropenic mice was investigated. Mice treated with a single dose of rG-CSF showed a significantly reduced mortality (28% vs. 90%; P õ .001). The outgrowth of C. albicans from the kidneys, spleens, and livers of rG-CSF -treated mice was significantly reduced (log cfu/g of kidney, 5.54 vs. 7.13; P õ .001), as were circulating tumor necrosis factor-a and interleukin-1b. After rG-CSF, the kidneys showed fewer infectious infiltrates, enhanced granulocyte influx, and almost complete absence of hyphal outgrowth. During peritoneal C. albicans infection, rG-CSF enhanced influx of granulocytes to the site of infection, and exudate granulocytes showed increased oxygen radical production. These results indicate that rG-CSF enhances host resistance to disseminated candidiasis in nonneutropenic mice through activation of granulocytes and their recruitment to the site of infection.
Disseminated candidiasis is being recognized with increasing superoxide production [7, 8] . Previous studies have demonstrated a beneficial effect on the course of experimental infecfrequency in patients with a variety of underlying diseases [1] . Although various new antifungal drugs have been developed tion with Candida albicans when recombinant (r) G-CSF was administered prophylactically to prevent neutropenia. Repeated recently, mortality due to disseminated candidiasis remains high, even in nonneutropenic hosts [2] . Therefore, it would be administration of rG-CSF effectively precludes the development of severe cyclophosphamide-induced neutropenia and rational to focus on augmentation of host defense mechanisms in addition to conventional antifungal therapy [3] . There is vast protects animals against a subsequent lethal challenge with C. albicans [9, 10] . However, very few data exist on the potenevidence that neutrophils (PMNL) constitute the main mechanism of host defense against invasive and disseminated candiditial role of rG-CSF in disseminated candidiasis or other infections in nonneutropenic animals. In the present study, we have asis [4] . Candida blastospores can be phagocytized and killed by phagocytic cells, and PMNL are able to kill Candida pseuinvestigated the effect of prophylactic and therapeutic administration of recombinant murine G-CSF on experimental dissemdohyphae and hyphae through both oxidative and nonoxidative mechanisms, even without ingesting the latter forms [3] . It is inated C. albicans infection in nonneutropenic mice. Thus far, studies have used human recombinant G-CSF in mice. Since conceivable that augmenting either the number of PMNL or their microbicidal capacity will enhance the resistance to disthe activity of the human molecule is considered suboptimal in mice, we performed our studies with recombinant murine seminated candidiasis in nonneutropenic hosts.
Granulocyte colony-stimulating factor (G-CSF) is a hemato-G-CSF, which has recently become available. Furthermore, these studies address the effects of rG-CSF on circulating cytopoietic growth factor that selectively stimulates the proliferation and maturation of myeloid progenitor cells [5, 6] . In addikines, the recruitment of PMNL to the site of infection, and on the induction of reactive oxygen intermediates during tion to its effect on PMNL numbers, G-CSF has been shown to enhance a variety of functional properties of PMNL, such C. albicans infection. as chemotaxis, expression of cellular adhesion molecules, and did. C. albicans UC820 was inoculated into 100 mL of Sabouraud cytes per cubic millimeter and the differential counts of 200 leukocytes in two Giemsa-stained blood smears. broth and cultured for 24 h at 37ЊC. After three washes with Cytokine assays. Blood (100 mL) was obtained by orbital pyrogen-free saline by centrifugation at 1500 g, the number of bleeding into Eppendorf tubes containing 2 mg of EDTA. The yeast cells was counted in a hemacytometer; occasional strings of blood was centrifuged (5 min, 7500 g), and the plasma was pooled §2 yeasts were counted as 1 cfu of C. albicans. The suspension and stored at 020ЊC until assayed for cytokines. Interleukin was diluted to the appropriate concentration with pyrogen-free (IL)-1a, IL-1b, and tumor necrosis factor (TNF)-a were detersaline. The viability of the yeasts was at least 98%, as determined mined by an RIA as described earlier [14] . by methylene blue exclusion and confirmed by plating serial diluChemiluminescence assay. Luminol-enhanced chemiluminestions onto Sabouraud dextrose agar plates.
cence was used as a measure of the respiratory burst as described Infection model. Mice were injected intravenously (iv) with previously [15] . In brief, peritoneal exudate cells were obtained 5 1 10 5 cfu of C. albicans in 100 mL of pyrogen-free saline. from mice that had received an ip injection of C. albicans 4 h rG-CSF was given as a subcutaneous (sc) injection of 500 ng (25 earlier, and 1 1 10 6 cells were resuspended in 100 mL of PBS mg/kg) in 100 mL of pyrogen-free saline at various time points in polypropylene chemiluminescence cuvettes (LKB; Bio-Orbit, before or during infection. Control mice received 100 mL of pyroTurku, Finland) with 4 mg of opsonized zymosan (Sigma) in 100 gen-free saline sc. Survival was assessed twice daily. Subgroups mL of PBS and 700 mL of luminol, 10 04 M (Sigma). Chemilumiof animals were anesthetized with ether and killed by cervical nescence was read at 37ЊC during 2 h with an LKB-Wallac type dislocation on days 1 or 3 of infection, and blood was collected 1251 chemiluminometer (Bio-Orbit) and expressed as the total for the measurement of plasma cytokine concentrations. To assess amount of superoxide produced during the assay period by intethe outgrowth of the microorganisms in the liver, spleen, and kidgrating the area under the curve (in millivolts 1 second) per neys, the organs were removed aseptically, weighed, and homoge-PMNL. nized in sterile saline in a tissue grinder. The number of viable Statistical analysis. The results obtained for the various treat-C. albicans cells in the tissues was determined by plating serial ment groups were analyzed by the Mann-Whitney U test and, dilutions on Sabouraud dextrose agar plates as described prewhen appropriate, by analysis of variance. Survival curves were viously [12] , and colony-forming units (cfu) were counted after analyzed by the Kaplan-Meier log-rank test. For all comparisons, overnight incubation at 37ЊC. The results were expressed as the the level of significance between groups was set at P õ .05. All log cfu per gram of tissue. From other groups of animals, the experiments were done at least twice. kidneys and the liver were removed and fixed in buffered formalin (4%), and serial sections were examined microscopically after staining with periodic acid-Schiff or with hematoxylin-eosin. To assess the role of PMNL in the rG-CSF-mediated protection
Results
against disseminated candidiasis, a subgroup of animals was rendered granulocytopenic by pretreatment with cyclophosphamide day before infection or repeated doses of 200 ng of rG-CSF, ( figure 3C ). In animals that had received a single dose of rG-CSF 30 min after infection, the infectious foci were less compared with 90% mortality in untreated animals (P õ .01).
Effect of rG-CSF treatment on acute disseminated candidia-
Time of administration of rG-CSF. In the model of rapidly numerous than in controls ( figure 3D ). In rG-CSF -treated animals, the inflammatory infiltrates contained larger amounts of lethal infection, the effect of a single dose of rG-CSF was greatest when given 24 h before injection of C. albicans (table PMNL (figure 3F), with fewer yeasts present. In contrast to untreated controls, candidae were almost completely present 1). Mice treated with a single dose of 500 ng of rG-CSF 30 min after injection of 5 1 10 5 cfu of C. albicans showed a in the yeast form, and in most infiltrates, hyphae were absent (figure 3E). Although administration of a single dose of reduced 21-day mortality (56%) compared with control mice (P õ .05). The outgrowth of C. albicans in the kidneys and rG-CSF to mice as late as 24 h after infection neither enhanced survival of mice nor significantly reduced the number of cfu spleen of mice treated with rG-CSF 30 min after infection was significantly lower than in controls on day 1 and 3 of infection, in their organs, a reduced outgrowth of pseudohyphae, as well as an enhanced influx of PMNL at the sites of infection, was although the differences were quantitatively rather small (table  1) . When administration of rG-CSF was delayed until 24 h seen on microscopic examination (figure 3G, H).
Circulating cytokines during acute disseminated candidiasis after injection of C. albicans, neither a significant effect on mortality (data not shown) nor an effect on the outgrowth of in nonneutropenic mice. The concentrations of circulating TNF-a and IL-1a are shown in figure 4 . On day 1 of infection, microorganisms was found (table 1) .
Effect of rG-CSF on the histopathology of the kidneys during TNF-a plasma concentrations were significantly lower in animals that had received a single dose of rG-CSF 24 h before acute disseminated candidiasis. On gross examination, the kidneys of untreated control animals showed multiple abscesses infection compared with levels in control mice (72 { 36 pg/mL vs. 252 { 95 pg/mL, P õ .01). On day 3 of infection, at day 3 of infection. Microscopically, numerous infectious foci were found in periodic acid -Schiff -stained sections (figcirculating TNF-a in rG-CSF -treated animals was also lower than in control animals (figure 4; P Å .06). In animals that ure 3A), with extensive hyphal outgrowth of C. albicans as well as yeast forms ( figure 3B ). In hematoxylin-eosin -stained received repeated injections of rG-CSF on days 01 through /3 of infection, circulating TNF-a was also reduced on day sections, relatively few PMNL could be found at these sites 1 (P õ .01) and day 3 (P Å .06) of infection. Circulating chemiluminescence as well as the chemiluminescence expressed per exudate PMNL were significantly increased in the IL-1a concentrations were lower in mice treated with rG-CSF than in controls on day 1 of infection only, both in animals animals pretreated with rG-CSF 1 day before peritoneal infection (0.27 vs. 0.15 mVrs/PMNL; P õ .05). treated with a single dose of rG-CSF (P Å .07) and in those having received repeated doses (P õ .05; figure 4) . No differTreatment of mice with catalase, an inhibitor of reactive oxygen intermediates, 30 min after infection, led to increased ences in IL-1a plasma concentrations were observed on day 3 of infection. Circulating concentrations of IL-1b were below mortality, the mean survival time being 2.7 days in catalasetreated animals and 7.3 days in control mice after injection of the detection limit in all treatment groups (data not shown).
Effect of rG-CSF on the numbers and function of granulo-5 1 10 5 cfu of C. albicans (P õ .001). Administration of catalase did not significantly influence the outgrowth of Cancytes during infection.
In untreated mice, the mean number of peripheral blood PMNL before infection was 2.1 { 0.7 dida cfu in the kidneys (data not shown), but administration of catalase simultaneously with rG-CSF completely abrogated 1 10 9 /L. At the time of injection of C. albicans, the number of PMNL was 2.6 { 1.3 1 10 9 /L in mice given rG-CSF 1 day the protective effect of rG-CSF on mortality and tissue burden of microorganisms, arguing for an effect of rG-CSF through earlier (P ú .05). Twenty-four hours after injection of C. albicans, no significant changes had occurred in the numbers activating PMNL. Survival and outgrowth of candidae did not differ significantly between mice treated with catalase alone or of PMNL in control mice (2.5 { 1.9 1 10 9 /L), mice pretreated with a single dose of rG-CSF (2.6 { 2.4 1 10 9 /L), or mice with the combination of catalase and G-CSF (data not shown).
Administration of rG-CSF to neutropenic mice and effects that had received daily injections of rG-CSF (3.2 { 2.6 1 10 9 /L; P ú .05). On day 3 of infection, the numbers of PMNL on growth of C. albicans in vitro. To investigate whether the observed protective effect of rG-CSF on disseminated candidiawere unchanged in control mice (2.5 { 0.7 1 10 9 /L) and mice that had received a single dose of rG-CSF (2.6 { 0.6 1 sis may have been at least in part mediated by mechanisms other than recruitment and activation of PMNL, mice received 10 9 /L), whereas the numbers of PMNL in mice treated with repeated daily doses of 500 ng of rG-CSF were significantly repeated injections of cyclophosphamide on alternate days, which has been shown to induce a profound and sustained increased (5.5 { 2.4 1 10 9 /L; P õ .005). The mean numbers of blood lymphocytes and monocytes did not change significantly neutropenia [13] . In these animals, rG-CSF was administered as late as at the time of infection to preclude an effect on bone during the course of the infection in either rG-CSF -treated mice or controls (data not shown). marrow recovery. Injection of 500 ng of rG-CSF simultaneously with the injection of 1 1 10 4 cfu of C. albicans had no Peritoneal cell exudates harvested from uninfected control mice consisted of ú98% macrophages and elicited no detecteffect on either the numbers of PMNL or the course of infection, the mortality being 100% after 7 days in rG-CSF -treated able chemiluminescence on stimulation with zymosan (data not shown). After intraperitoneal injection of 10 7 cfu of C. albicans, mice as well as control mice. There were no differences in the outgrowth of C. albicans in the kidneys, spleen, and liver bethe number of peritoneal PMNL showed a sharp rise, to 1.5 { 0.3 1 10 9 /L at 4 h after injection. The number of exudate tween rG-CSF -treated and untreated neutropenic mice (data not shown), indicating that the effect of rG-CSF is indeed PMNL in mice that had received 500 ng of rG-CSF 1 day before the infection was significantly higher than that in control mediated through PMNL. Incubation of C. albicans in Sabouraud broth with 10 -1000 ng/mL rG-CSF did not influence the mice or in mice that had received rG-CSF 4 h earlier (2.6 { 0. 
Discussion
PMNL recruitment. G-CSF not only increases the numbers of PMNL, their chemotaxis, and expression of cellular adhesion molecules but also has been shown to enhance their microbiciThe results of the present study show that a single injection dal function in vitro [8, 17] . When mice were infected ip with of rG-CSF beneficially influences the course of potentially le-C. albicans, treatment with rG-CSF not only increased the thal acute disseminated candidiasis in nonneutropenic mice.
influx of PMNL to the site of infection but also augmented the Treatment with rG-CSF reduced the mortality and significantly production of reactive oxygen intermediates by these cells, as decreased the outgrowth of C. albicans in the organs of the was demonstrated by the increased chemiluminescence exanimals. Although the low dose of rG-CSF that was adminispressed per cell. Moreover, catalase, which is an inhibitor of tered in our study had no effect on the numbers of PMNL the respiratory burst [18] , completely abrogated the protective in the circulation during acute disseminated candidiasis, the effect of rG-CSF in our model. It has been demonstrated earlier histopathology of the kidneys showed a noticeable increase in that stimulation of PMNL with rG-CSF in vitro is able to numbers of PMNL at the actual sites of infection, indicating augment the intracellular killing of C. albicans [19] and to that PMNL that were mobilized by rG-CSF were rapidly diincrease the release of reactive oxygen intermediates on stimurected to the infected organs. The difference in numbers of lation with Candida blastospores or pseudohyphae in vitro [20] . PMNL at these sites between control mice and rG-CSF -treated Although the effect of rG-CSF in this model of acute overanimals suggests that the inability to attain a sufficient mobiliwhelming candidiasis was maximal when given 24 h before zation of PMNL at the site of infection may be an important the infection, a significant beneficial effect was also found determinant of the course of invasive candidiasis and that rG-CSF may be able to improve the outcome by enhancing when given 30 min after the injection of the microorganisms. When treatment with rG-CSF was begun as late as 24 h after administration of a high dose (50 mg/kg/day) of rG-CSF was begun before infection [26] . In similar experimental models, infection, no significant improvement in survival was found. Although the actual experiment shown in table 1 suggests that rG-CSF alone was not effective, whereas combination therapy with fluconazole or itraconazole, but not amphotericin B or there was a tendency toward increased outgrowth of C. albicans at day 3 after infection when rG-CSF was given 24 h after flucytosine, appeared to be synergistic, but only when begun before or immediately after infection and only when small infection, this trend has not been observed in repeated experiments or at other time points. Moreover, the histopathology of amounts of C. albicans were injected [23, 27] .
In the present study, we have demonstrated a beneficial effect the infected kidneys suggested a beneficial effect of this treatment schedule on the course of infection. It is conceivable that of rG-CSF on survival of mice with acute disseminated candidiasis and also in reducing the outgrowth of candidae from the rG-CSF may be effective when given at later time points in models of subacute and less overwhelming disseminated canditarget organs and the histopathologic damage to the kidneys, as well as a beneficial effect on recruitment of PMNL to the diasis or when combined with antifungal drugs, which is currently under study in our laboratory.
site of infection. Remarkably, treatment with rG-CSF led to a reduction in the concentrations of circulating TNF-a and Although very few data have been published on the application of rG-CSF in nonneutropenic animals with infection, sev-IL-1a during the infection, in spite of the increased influx of inflammatory cells at the sites of infection. Although G-CSF eral authors have studied the effect of rG-CSF on disseminated candidiasis in neutropenic animals. In these studies, animals is capable of directly inhibiting the production of TNF-a [28] , we have shown earlier that mortality due to acute disseminated have been rendered neutropenic by relatively low doses of cyclophosphamide and were subsequently treated with rG-CSF, candidiasis is mediated through outgrowth of the microorganisms, leading to organ destruction, rather than through lethal leading to at least partial recovery of the numbers of PMNL before the microorganisms were injected [10, 21 -24] . Therecirculating concentrations of proinflammatory cytokines [29] . It may be hypothesized that the reduced cytokine concentrafore, in those studies, the susceptibility of rG-CSF -treated nonneutropenic mice was compared with that of control anitions are at least in part a result of the reduced outgrowth of C. albicans in the tissues. mals that were still neutropenic at the moment of infection. The results of such studies clearly indicate the importance of Other hematopoietic growth factors may as well have a beneficial effect on disseminated candidiasis. Granulocyte-macroearly PMNL recovery to prevent the development of fungal infections. From our experiments, it is clear that rG-CSF does phage colony-stimulating factor has been shown to augment the intracellular killing of C. albicans and to enhance superoxide not improve survival in the sustained absence of PMNL. These findings are in accordance with studies on chronic disseminated production by PMNL in vitro [19] . Incubation with purified murine macrophage colony-stimulating factor (M-CSF) inhibcandidiasis in rabbits with a persisting and profound neutropenia, in which no effect of the administration of rG-CSF was its the outgrowth of C. albicans in murine peritoneal exudate macrophages [30] . Treatment of chronic disseminated candidifound [25] .
Few studies have been published on the role of rG-CSF in asis in rats with rM-CSF has been shown to reduce the outgrowth of C. albicans [31] , but others found that administration acute or chronic disseminated candidiasis in nonneutropenic animals. In one study, rG-CSF had a beneficial effect on mortalof rM-CSF either before infection or commencing at the moment of infection aggravated the course of acute overwhelming ity due to acute candidiasis only when given prophylactically as early as 3 days before infection but not when given later or candidiasis in mice [32] .
In conclusion, we have demonstrated a beneficial effect of in multiple doses [10] . Others recently have reported a beneficial effect on the mean survival time of mice when repeated rG-CSF on acute disseminated candidiasis in mice, significantly
